Showing 1–18 of 52 results
-
$0.00
উচ্চ রক্ত শর্করা (High blood sugar) এবং ডায়াবেটিস ওষুধ সম্পর্কিত সর্বশেষ বইগুলির মধ্যে এই বইটি একটি।
- ডায়াবেটিস এত সাধারণ এবং একই কারণে ডায়াবেটিস পরিচালনা এবং চিকিৎসা সম্পর্কে ব্যাপক গবেষণা হয়েছে।
- এটি ড্রাগ/ ওষুধ সংস্থাগুলির জন্য সাধারণ অর্থনীতি কারণ ডায়াবেটিস এত সাধারণ যদি তারা একটি নতুন ওষুধ তৈরি করে তবে এটি সংস্থাকে খুব ধনী করে তুলবে।
- ফার্মাসিউটিক্যাল সংস্থাগুলি যখন নতুন ওষুধ তৈরি করছে, সেগুলি খুব সমৃদ্ধ হতে পারে তবে এটি আমাদের খুব সুস্থ রাখবে।
- যদি আমাদের রক্তে শর্করার পরিমাণ বাড়তে থাকে কিন্তু আমরা যদি প্রাথমিক ব্যবস্থা শুরু করি তবে আমরা ৩০ বছর পর্যন্ত ডায়াবেটিস এবং জটিলতায় বিলম্ব করতে পারি।
- এই বইটি আমাদের নতুন প্রজন্মের sulfonylureas সাথে পরিচয় করিয়ে দেয় যা আমাদের দেহকে আমাদের জন্য উপলব্ধ ইনসুলিনের পরিমাণ বাড়াতে সহায়তা করে।
- একই বর্ণনা বুক ৩.১ ডায়াবেটিসের ক্ষেত্রে প্রযোজ্য। আমরা সবেমাত্র বইটির নম্বর দেখেছি। এই বইটি আপনাকে প্রথম প্রজন্মের sulfonylureas সম্পর্কে জানায় যা একটি গ্রুপের ওষুধ যা আমাদের দেহকে আরও ইনসুলিন মুক্ত করতে এবং সহায়তা করতে সহায়তা করে
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
$0.00
This book is one of the series of books on latest medications in relation to high blood sugar and diabetes.
- Diabetes is so common and for the same reason there has been huge research in management and treatment of diabetes.
- It is simple economics for research drug companies as diabetes is so common. If they make a new medicine, it will make the company very rich.
- While drug companies are making new medications may be very rich, but it will keep us very healthy.
- If our blood sugar is becoming higher, we can delay diabetes and complications by 30 years if we start management early.
- This book introduces us to the new generation of sulfonylureas which help our body to increase the amount of insulin available to us.
- Same description applies to book 3.1 diabetes also. We have just seen the number of the book. This book tells you about first generation sulfonylureas which is a group of medicines which helps our body to release and make available more insulin.
Add to cart
-
-
$0.00
উচ্চ রক্ত শর্করা (High blood sugar) এবং ডায়াবেটিস ওষুধ সম্পর্কিত সর্বশেষ বইগুলির মধ্যে এই বইটি একটি।
- ডায়াবেটিস এত সাধারণ এবং একই কারণে ডায়াবেটিস পরিচালনা এবং চিকিৎসা সম্পর্কে ব্যাপক গবেষণা হয়েছে।
- এটি ড্রাগ/ ওষুধ সংস্থাগুলির জন্য সাধারণ অর্থনীতি কারণ ডায়াবেটিস এত সাধারণ যদি তারা একটি নতুন ওষুধ তৈরি করে তবে এটি সংস্থাকে খুব ধনী করে তুলবে।
- ফার্মাসিউটিক্যাল সংস্থাগুলি যখন নতুন ওষুধ তৈরি করছে, সেগুলি খুব সমৃদ্ধ হতে পারে তবে এটি আমাদের খুব সুস্থ রাখবে।
- যদি আমাদের রক্তে শর্করার পরিমাণ বাড়তে থাকে কিন্তু আমরা যদি প্রাথমিক ব্যবস্থা শুরু করি তবে আমরা ৩০ বছর পর্যন্ত ডায়াবেটিস এবং জটিলতায় বিলম্ব করতে পারি।
- এই বইটি আমাদের নতুন প্রজন্মের sulfonylureas সাথে পরিচয় করিয়ে দেয় যা আমাদের দেহকে আমাদের জন্য উপলব্ধ ইনসুলিনের পরিমাণ বাড়াতে সহায়তা করে।
- একই বর্ণনা বুক ৩.১ ডায়াবেটিসের ক্ষেত্রে প্রযোজ্য। আমরা সবেমাত্র বইটির নম্বর দেখেছি। এই বইটি আপনাকে প্রথম প্রজন্মের sulfonylureas সম্পর্কে জানায় যা একটি গ্রুপের ওষুধ যা আমাদের দেহকে আরও ইনসুলিন মুক্ত করতে এবং সহায়তা করতে সহায়তা করে
Add to cart
-
$0.00
- এই বইটি ডায়াবেটিসের চিকিৎসার জন্য Glinides গ্রুপের ওষুধগুলির একটি অন্তর্দৃষ্টি দেয়।
- এটি Glinides কীভাবে গ্লুকোজ হ্রাসকারী ওষুধগুলি এবং ইনসুলিন নিঃসরণে কাজ করে সে সম্পর্কে তথ্য সরবরাহ করে।
- এটি Glinide গ্রুপের অধীনে তিনটি ওষুধের তথ্য সরবরাহ করে – Repaglinide, Nateglinide and Mitiglinide।
- ডায়াবেটিসের চিকিৎসার জন্য মেটফরমিনের দ্বিতীয় ওষুধ হিসাবে Repaglinide এবং Nateglinide যুক্ত করা যেতে পারে।
- ডায়েট এবং ব্যায়ামের পাশাপাশি এই ওষুধগুলি কার্যকরভাবে ব্লাড সুগার কমাতে সহায়তা করে।
Add to cart
-
$0.00
- The book gives an insight into the Glinides group of medicines for treatment of Diabetes.
- It provides information about the working of Glinides as to how these are glucose lowering medicines and that they act by releasing insulin.
- It provides information about three medicines under the Glinide group - Repaglinide, Nateglinide and Mitiglinide.
- Repaglinide and Nateglinide can be added as second medicine to Metformin for treatment of diabetes.
- Along with diet and exercise, these medicines can help lower blood sugar effectively.
Add to cart
-
$0.00
- The book gives an insight into the Glinides group of medicines for treatment of Diabetes.
- It provides information about the working of Glinides as to how these are glucose lowering medicines and that
they act by releasing insulin.
- It provides information about three medicines under the Glinide group – Repaglinide, Nateglinide and Mitiglinide.
- Repaglinide and Nateglinide can be added as second medicine to Metformin for treatment of diabetes.
- Along with diet and exercise, these medicines can help lower blood sugar effectively.
Add to cart
-
$0.00
- यह बुक डायबिटीज के इलाज के लिए दवाओं के ग्लिनाइड्स समूह के बारे में एक अंतर्दृष्टि (Insight) देती है।
- यह ग्लिनाइड्स के काम करने के तरीके के बारे में जानकारी प्रदान करती है कि यह कैसे ग्लूकोज कम करने वाली दवाइयाँ हैं और यह इंसुलिन जारी करके कार्य करती हैं।
- यह ग्लिनाइड्स समूह - रेपेग्लिनाइड, नेटेग्लाइनाइड और मिटिग्लिनाइड के तहत तीन दवाओं के बारे में जानकारी प्रदान करता है।
- डायबिटीज के इलाज के लिए मेटफार्मिन की दूसरी दवा के रूप में रेपेग्लिनाइड और नेटेग्लाइनाइड को मिलाया जा सकता है।
Add to cart
